RESUMO
Sexual dysfunction is common in women with infertility and interferes with the marital relationship. The study aims to compare sexual function among women with different infertility causes. The authors used a cross-sectional study design with 142 infertile women. Sexual functions and depression prevalence of infertile women were assessed using the Female Sexual Function Index and the Beck Depression Inventory. The prevalence of female sexual dysfunction was 43.3% (n = 13) in the female infertility group (Group A), 54.8% (n = 17) in the male infertility group (Group B), and 51.9% (n = 42) in the unexplained infertility group (Group C). There was no statistically significant difference in the prevalence of sexual dysfunction between the groups (p =.635). There was no significant difference in mean Beck Depression Inventory scores between the groups (p =.832). However, Beck Depression Inventory scores and depression prevalence were significantly higher in women with sexual dysfunction (p <.001). The total Female Sexual Function Index score and all subgroup scores were inversely correlated with the Beck Depression Inventory score (p <.01). Infertile women with sexual dysfunction were more likely to have depressive symptoms. Psychiatric assessment should be introduced in the management of infertility.
RESUMO
The aim of this study was to determine the effect of ursodeoxycholic acid (UDCA) treatment on a polycystic ovary syndrome (PCOS) rat model. Thirty-two female Wistar-Albino rats were randomly divided into four groups as follows - group 1: sham group (n: 8), group 2: letrozole-induced PCOS group (n: 8), group 3: letrozole-induced PCOS plus metformin-treated (500 mg/kg) group (n: 8) and group 4: letrozole-induced PCOS plus UDCA (150 mg/kg)-treated group (n: 8). Histopathologic examination of the ovaries, circulating estrone (E1), estradiol (E2), testosterone, androstenedione, glucose, insulin and lipid profiles were evaluated. Histopathologic examination results revealed that groups 3 and 4 had significantly lower cystic and atretic follicles compared to group 2. Besides, group 4 had significantly higher antral follicles than group 2 (8.5 ± 2.9 versus 5.4 ± 1.1; p: 0.001). Furthermore, total testosterone (4.9 ± 2.8 versus 8.8 ± 2.9; p= 0.004) and insulin levels were significantly lower in group 4 compared to group 2 (1.7 ± 0.08 versus 2.1 ± 0.5; p = 0.02). However, lipid parameters, E1, E2, glucose and HOMA-IR were comparable between the groups. Our study results demonstrated that UDCA therapy improves ovarian morphology and decreases total testosterone and insulin levels.
Assuntos
Colagogos e Coleréticos/farmacologia , Ovário/efeitos dos fármacos , Síndrome do Ovário Policístico/sangue , Síndrome do Ovário Policístico/tratamento farmacológico , Ácido Ursodesoxicólico/farmacologia , Animais , Colagogos e Coleréticos/administração & dosagem , Modelos Animais de Doenças , Feminino , Ratos , Ratos Wistar , Ácido Ursodesoxicólico/administração & dosagemRESUMO
PURPOSE: To investigate whether there is any therapeutic effect of colchicine on a rat model of polycystic ovary syndrome (PCOS). METHODS: Twenty-two Wistar-Albino rats were randomly assigned into four with 8 rats in each group: control group; PCOS only group; PCOS-metformin group and PCOS-colchicine group. PCOS was induced by gavage with letrozole once daily at the concentration of 1 mg/kg orally with 21 consecutive days. After PCOS model assessment, PCOS-metformin group was received metformin orally with 500 mg/kg and PCOS-colchicine group was received colchicine orally with 1 mg/kg for the 35 day. Histopathology of ovaries, circulating estrone (E1), estradiol (E2), total testosterone, androstenedione and c-reactive protein (CRP) levels were evaluated. RESULTS: cystic and atretic follicle number was significantly decreased, but CRP and hormone parameters were not significantly changed with colchicine treatment. CONCLUSION: Colchicine has provided histopathological improvement compared with metformin in PCOS rat model.
Assuntos
Colchicina/administração & dosagem , Metformina/administração & dosagem , Folículo Ovariano/efeitos dos fármacos , Síndrome do Ovário Policístico/tratamento farmacológico , Moduladores de Tubulina/administração & dosagem , Androstenodiona/sangue , Animais , Proteína C-Reativa/metabolismo , Colchicina/uso terapêutico , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Estradiol/sangue , Feminino , Humanos , Metformina/uso terapêutico , Ovário/efeitos dos fármacos , Ovário/patologia , Síndrome do Ovário Policístico/sangue , Síndrome do Ovário Policístico/induzido quimicamente , Síndrome do Ovário Policístico/patologia , Distribuição Aleatória , Ratos , Ratos Wistar , Testosterona/sangue , Moduladores de Tubulina/uso terapêuticoRESUMO
OBJECTIVE: Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder affecting 5-10% of women in reproductive age. Insulin resistance, dyslipidemia, glucose intolerance, hypertension, and obesity are metabolic disorders accompanying the syndrome. PCOS is a chronic proinflammatory state and the disease is associated with endothelial dysfunction. In diseases with endothelial damage, hearing in high frequencies are mostly effected in early stages. We evaluated extended high frequency hearing loss in PCOS patients. MATERIAL METHODS: Forty women diagnosed as PCOS and 25 healthy controls were included in this study. Age and BMI of PCOS and control groups were comparable. Each subject was tested with low (250-2000 Hz), high (4000-8000 Hz), and extended high frequency audiometry (8000-20000). Hormonal and biochemical values including LH, LH/FSH, testosterone, fasting glucose, fasting insulin, HOMA-I, and CRP were calculated. RESULTS: PCOS patients showed high levels of LH, LH/FSH, testosterone, fasting insulin, glucose, HOMA-I, and CRP levels. The hearing thresholds of the groups were similar at frequencies of 250, 500, 1000, 2000, and 4000 Hz; statistically significant difference was observed in 8000-14000 Hz in PCOS group compared to control group. CONCLUSION: PCOS patients have hearing impairment especially in extended high frequencies. Further studies are needed to help elucidate the mechanism behind hearing impairment in association with PCOS.
Assuntos
Audiometria/métodos , Perda Auditiva de Alta Frequência/etiologia , Síndrome do Ovário Policístico/complicações , Adulto , Glicemia/análise , Proteína C-Reativa/análise , Estudos de Casos e Controles , Feminino , Hormônio Liberador de Gonadotropina/sangue , Perda Auditiva de Alta Frequência/diagnóstico , Humanos , Resistência à Insulina , Hormônio Luteinizante/sangue , Síndrome do Ovário Policístico/sangue , Testosterona/sangue , Adulto JovemRESUMO
OBJECTIVES: In this study, we aimed to present newborn hearing screening results performed at Zeynep Kamil Women and Children Diseases Education and Research Hospital, a reference hospital, within the past one year in the light of literature review. PATIENTS AND METHODS: Between January 1, 2010 and December 31, 2010, a total of 11.053 babies who were born in our hospital or referred to our hospital from other health care centers were included. All babies who were born in our hospital underwent transient evoked otoacustic emission (TEOAE) test within 10 days after birth. In addition, the babies younger than six months only who were referred to our hospital underwent the screening test. A detailed otological examination was performed on the babies who failed to pass the test and then hearing screening was done by automated auditory brainstem response (ABR) device (Bio-logic). Also, otoacustic emission and ABR tests were performed together on the babies who were considered at high risk for permanent congenital hearing loss. RESULTS: Of a total of 11.053 babies who underwent hearing screening, 8.490 (76.9%) passed the initial test. The results of stepwise test including three steps revealed that hearing loss was present in 17 babies (0.15%). CONCLUSION: Newborn hearing loss is the leading factor which impairs the speech and language development, if not diagnosed earlier. Hearing screening tests should be expanded throughout the country as soon as possible and the babies with hearing loss should be identified before permanent damages occur. As a result, these babies can be saved from being disabled and they can be raised as self-sufficient individuals who can contribute to the society.
Assuntos
Perda Auditiva/epidemiologia , Testes Auditivos , Triagem Neonatal , Potenciais Evocados Auditivos do Tronco Encefálico , Feminino , Perda Auditiva/diagnóstico , Hospitais Universitários , Humanos , Lactente , Bem-Estar do Lactente , Recém-Nascido , Masculino , Emissões Otoacústicas Espontâneas , Turquia/epidemiologiaRESUMO
AIM: To evaluate maternal and cord blood irisin levels in pregnant women with gestational diabetes mellitus (GDM) and in obese pregnant women without GDM. METHODS: The study included 109 patients, with 34 patients in the GDM group, 40 in the obese non-GDM group, and 35 in the control group. Maternal serum irisin levels at the time of delivery were measured by an enzyme-linked immunosorbent assay kit. The correlation of serum irisin levels with metabolic parameters and anthropometric measurements was analyzed. RESULTS: There were significant differences between the study groups in terms of cord arterial, cord venous, and maternal serum irisin levels (P < 0.001, P < 0.01, P < 0.001, respectively). Cord arterial, cord venous, and maternal serum irisin levels were higher in the obese group compared to the control (P < 0.01, P < 0.01, P < 0.01, respectively) and the GDM group (P < 0.001, P < 0.001, P < 0.001, respectively). CONCLUSION: Elevation in irisin levels of women who have pregnancies complicated with obesity may be explained as part of the compensation mechanism against disturbed metabolic functions. Pregnant individuals with GDM have lower serum irisin levels in comparison to healthy pregnant women. In this regard, it is possible that the measurement of serum irisin levels may be utilized in the future for prediction, prevention, and treatment of GDM.
Assuntos
Diabetes Gestacional/sangue , Fibronectinas/sangue , Obesidade/sangue , Adulto , Estudos de Casos e Controles , Feminino , Sangue Fetal/metabolismo , Humanos , Gravidez , Adulto JovemRESUMO
AIM: There is an unclear relationship between Polycystic Ovary Syndrome and psychiatric disorders including anxiety and depression. We aimed to evaluate temperamental and personal characteristics of patients with PCOS. METHODS: Fifty patients with PCOS and 41 healthy controls were included in the study. Hormonal and demographic characteristics were recorded after gynecologic and psychiatric evaluation. Socio-demographical Data Form, Beck Depression Inventory, Beck Anxiety Inventory and the Cloninger's Temperament and Character Inventory were performed for all participants. RESULTS: Patients with Policystic Ovary Syndrome had significantly higher depression and anxiety scores when compared to the controls (p < 0.05). There were no significant difference in any of the subdimensions neither for temperament nor for character between patient and control groups (p > 0.05). Testosteron levels and the degree of hirsutism, LH/FSH ratio and body mass index of the patients did not have significant correlations with depression or anxiety scores or any of the Cloninger subdimentions (p > 0.05). However, there was a negative correlation between age and novelty seeking and age and reward dependence (r:-0.33, p:0.018; r:-0.295, p:0.037, respectively). CONCLUSIONS: This preliminary study showed no significant difference between patients and healthy controls regarding temperament and character. Patients had higher anxiety and depression scores. Further research is needed to enlighten this subject.
Assuntos
Caráter , Síndrome do Ovário Policístico/psicologia , Temperamento , Adulto , Ansiedade/epidemiologia , Índice de Massa Corporal , Estudos Transversais , Depressão/epidemiologia , Feminino , Hormônio Foliculoestimulante/sangue , Hirsutismo , Humanos , Hormônio Luteinizante/sangue , Estudos Prospectivos , Testosterona/sangue , Adulto JovemRESUMO
OBJECTIVES: To determine the predictive value of antral follicle diameter variance within each ovary for ovarian response in cases with normal ovarian reserve tests. METHODS: This is a prospective observational study. One hundred and thirty nine infertile women who underwent ART in IVF-ICSI unit of Zeynep Kamil women and children's Health Training and research hospital between January 2017 to June 2017 were recruited. Blood samples were collected on day 2/day 3 for assessment of serum FSH and estradiol. Trans-vaginal sonography was done for antral follicle count. During antral follicle count, in order to determine antral follicle diameter variance, diameters of the largest and smallest follicles were recorded. Variance was calculated by subtracting the smallest diameter from the largest one. Following ovarian stimulation with antagonist protocol, poor response was determined in cases with total oocyte number≤3. Ovarian reserve tests and antral follicle diameter variance were utilized to predict cases with poor response in women with normal ovarian reserve. RESULTS: Antral follicle diameter variance both in right (AUC=0.737, P<0.001) and left (AUC=0.651, P<0.05) ovaries significantly predicted poor ovarian response. Variance>3.5 mm was found to have 75% sensitivity to predict poor response. Basal serum FSH with estradiol levels and AFC failed to predict poor response (P>0.05). Other significant predictors for poor response were day 5 estradiol level and estradiol level at trigger day (P<0.05). In multivariate regression analysis, both AFC and antral follicle diameter variance in the right ovary were found to be significantly associated with clinical pregnancy, on the other hand peak estradiol concentration and antral follicle diameter variance in the right ovary were significantly associated with poor response. CONCLUSION: Antral follicle diameter variance may be utilized to predict poor ovarian response in cases with normal ovarian reserve.
Assuntos
Endossonografia/normas , Infertilidade Feminina/sangue , Infertilidade Feminina/terapia , Avaliação de Resultados em Cuidados de Saúde/normas , Folículo Ovariano/diagnóstico por imagem , Reserva Ovariana , Indução da Ovulação/métodos , Injeções de Esperma Intracitoplásmicas/métodos , Adulto , Endossonografia/métodos , Feminino , Humanos , Avaliação de Resultados em Cuidados de Saúde/métodos , Prognóstico , Estudos Prospectivos , Sensibilidade e Especificidade , Adulto JovemRESUMO
OBJECTIVE: Immediate skin-to-skin contact (ISSC) and early breastfeeding are recommended for the wellbeing of the neonate. In this study, we aimed to evaluate the effect of ISSC and early breastfeeding on maternal oxidative stress and postoperative pain. METHODS: A total of 90 patients were randomized into two groups based on the timing of skin-to-skin contact and breastfeeding. Group 1 (n = 45) was provided ISSC and breastfeeding in the operating room during the cesarean section (C/S). Group 2 (n = 45) breastfed their babies 1 h after the C/S. As markers of oxidative stress, maternal serum levels of total antioxidant status (TAS), total oxidant status (TOS) and oxidative stress indices (OSI) were evaluated. Maternal oxytocin levels and the relation between these parameters and postoperative pain were also evaluated. RESULTS: The postoperative TAS levels were significantly higher, whereas TOS and OSI levels were lower in Group 1 than Group 2. Negative correlations between oxytocin level and postoperative TOS and OSI were observed, as was a positive correlation between oxytocin level and postoperative TAS. CONCLUSIONS: The effect of ISSC and early breastfeeding on mothers was documented for the first time in this study. Our results demonstrated ISSC and early breastfeeding during C/S reduce maternal oxidative stress.
Assuntos
Antioxidantes/análise , Aleitamento Materno , Cesárea , Estresse Oxidativo , Pele , Adulto , Estudos de Casos e Controles , Feminino , Humanos , Recém-Nascido , Saúde Materna , Ocitocina/sangue , Dor Pós-Operatória , Gravidez , Estudos Prospectivos , Fatores de TempoRESUMO
Mucinous cystadenoma (MC) of the ovary is an unilateral, multilocular cystic benign epithelial tumor. Supposed to be hormone responsive, MC reaches huge sizes during pregnancy. Aortocaval compression is common during pregnancy, especially when the pregnant woman is in the supine position. However, the compression recovers with a change in position. The authors report the first case of a huge mucinous cystadenoma of the ovary complicating pregnancy and causing virilization, premature labor, and persistent supine hypotensive syndrome.
RESUMO
OBJECTIVE: We hypothesized that maternal and fetal circulations may be affected by moderately high altitudes. Therefore, we compared the differences in maternal and fetal Doppler flow parameters in women with term pregnancy living at a moderately high altitude (1890 m in Erzurum) with those of women living at the sea level (31 m in Istanbul). MATERIAL AND METHODS: Eighty women (n=40, for each group) with full-term and singleton pregnancies underwent Doppler waveform analysis, and the pulsatility and resistance index values for the uterine, umbilical, and mid-cerebral arteries were recorded. Also, sex, birth, and placental weights during delivery were obtained from the medical records. RESULTS: Similar mean placental weight values were found at the sea level compared with the moderately high altitude (p>0.05). The mean birth weight values were found to be lower at the moderately high altitude than those at the sea level (p<0.05). The pulsatility and resistance index values for the umbilical and mid-cerebral arteries were found to be similar between the groups (p>0.05). However, the pulsatility and resistance index values for both the right and left uterine arteries were higher at the sea level than those at moderately high altitude (p<0.05, for all). CONCLUSION: Moderately high altitude does not affect fetal vascular Doppler parameters. However, it appears to increase the uterine artery blood flow bilaterally, and these alterations in the bilateral uterine artery blood flow may be associated with a physiological adaptation to high altitude.
RESUMO
BACKGROUND: We aimed to estimate the glomerular filtration rate (GFR) in women with polycystic ovary syndrome (PCOS) and to determine the relationship between GFR with C-reactive protein (CRP) and uric acid. MATERIALS AND METHODS: In this cross-sectional study, one-hundred and forty PCOS women and 60 healthy subjects were evaluated. The study was carried out at Endocrinol- ogy Outpatient Clinic, Erzurum Training and Research Hospital, Erzurum, Turkey, from December 2010 to January 2011. GFRs were estimated by Modification of Diet in Renal Disease (MDRD) formula. CRP, urinary albumin excretion (UAE) and uric acid levels were also measured. RESULTS: GFRs were significantly higher in PCOS group than control (135.24 ± 25.62 vs. 114.92 ± 24.07 ml/min per 1.73 m(2)). CRP levels were significantly higher in PCOS patients (4.4 ± 3.4 vs. 2.12 ± 1.5 mg/l). The PCOS group had significantly higher serum uric acid levels (4.36 ± 1.3 mg/dl vs. 3.2 ± 0.73 mg/dl). There was also significantly higher proteinuria level in PCOS patients. CONCLUSION: Even though PCOS patients had higher GFR, serum uric acid and UAE val- ues than control patients, the renal function was within normal limits. Increased GFR in PCOS women positively correlates with elevated serum CRP and uric acid.
RESUMO
OBJECTIVE: To compare the initial serum magnesium levels between preterm labor (PL) and control groups and to evaluate MgSO4 treatment response in preterm labor group according to their initial serum magnesium levels. METHODS: Hundred women diagnosed as preterm labor between 28 and 33 weeks of gestation and 100 non-complicated pregnant women were enrolled in this prospective study. Total basal serum magnesium levels were measured in both the groups. After a 6 g intravenous bolus of MgSO4, a dose of 2 g/h was given as an infusion in the preterm labor group. RESULTS: Serum magnesium levels were significantly lower in preterm labor group (p < 0.001). The active contractions stopped in 69 (73,4%) preterm patients. The basal Mg level was significantly lower in this preterm group (1.6 versus 1.9, respectively, p < 0.001). Predictive value of basal magnesium level measurement for magnesium tocolysis response was calculated by receiver operating characteristic analyses with 95% confidence interval. Positive predictive and negative predictive values were found as 64.5% and 92.5%, respectively, with 83% accuracy, when cut-off magnesium value was taken as a <1.75 mg/dl (sensitivity = 80%, specificity = 84,1%). CONCLUSIONS: Basal magnesium levels in preterm labor had a predictive value in evaluating MgSO4 tocolysis response. It may help to select patients who are appropriate for MgSO4 tocolysis.
Assuntos
Sulfato de Magnésio/administração & dosagem , Magnésio/sangue , Trabalho de Parto Prematuro/diagnóstico , Trabalho de Parto Prematuro/tratamento farmacológico , Tocolíticos/administração & dosagem , Adulto , Cálculos da Dosagem de Medicamento , Feminino , Humanos , Recém-Nascido , Valor Preditivo dos Testes , Gravidez , Prognóstico , Resultado do Tratamento , Adulto JovemRESUMO
Imperforate Hymen (IH), an obstructive congenital anomaly of the female genital tract, is seen in 1 in 2000 female births. Treatment of IH is hymenotomy or hymenectomy. Different types of incisions are mentioned in the literature. We reported two cases of IH with different clinical presentations and described a simple virginity preserving and socially acceptable procedure to protect the virginity of the patient. In cultures and religions where the destruction of the hymen is a social problem in unmarried girls, virginity sparing surgery should be chosen in gynecological practice. Here we described a simple procedure without need for prophylactic antibiotic treatment and foley catheter application to form an intact annular hymen in two cases.